Jim Cramer Discusses Eli Lilly (LLY) Touching the Trillion Dollar Market Value
Eli Lilly and Company (NYSE:LLY) is one of Cramer’s top stocks in the pharmaceutical space.
Eli Lilly & Co (LLY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 4,453,062 | $3,397,687,594 | +4% | 1.23% |
| 2. | 2,327,200 | $1,775,653,600 | -38% | 0.27% | |
| 3. | 2,229,400 | $1,701,032,200 | +30% | 0.26% | |
| 4. | Citadel Investment Group Ken Griffin | 1,152,818 | $879,600,134 | +36% | 0.13% |
| 5. | Adage Capital Management Phill Gross And Robert Atchinson | 806,866 | $615,638,758 | -5% | 0.98% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $691.79 | 715 | $494,626.99 | 14,685 | 2025-08-15 | Filing | |
| $660.25 | 758 | $500,472.53 | 758 | 2025-08-13 | Filing | |
| $647.36 | 1,000 | $647,360.00 | 20,562 | 2025-08-13 | Filing | |
| $644.77 | 1,632 | $1,052,263.01 | 546,601 | 2025-08-12 | Filing | |
| $634.41 | 1,000 | $634,405.00 | 137,660 | 2025-08-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1,110.53 | 1,340 | $1,488,106.18 | 92,196,978 | 2025-11-25 | Filing | |
| $1,109.45 | 9,249 | $10,261,293.80 | 92,198,318 | 2025-11-25 | Filing | |
| $1,108.71 | 5,043 | $5,591,224.53 | 92,207,567 | 2025-11-25 | Filing | |
| $1,107.48 | 7,794 | $8,631,699.12 | 92,212,610 | 2025-11-25 | Filing | |
| $1,106.57 | 3,662 | $4,052,270.33 | 92,220,404 | 2025-11-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 95,492,993 | $72,861,153,659 | 100% | |
| 2. | 80,959,089 | $61,771,784,907 | 0.92% | |
| 3. | 65,809,763 | $50,212,850,031 | 0.88% | |
| 4. | 51,347,232 | $39,177,938,016 | 23.76% | |
| 5. | 34,726,558 | $26,496,363,754 | 0.92% |
News See All
JPMorgan Raises Eli Lilly (LLY) Price Target to $1,150, Maintains Overweight Rating
On November 18, JPMorgan analyst Chris Schott raised the firm’s price target on Eli Lilly and Company (NYSE:LLY) to $1,150 from $1,050 while maintaining an Overweight ratin...
11 Stocks Jim Cramer Shared His Insights On
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer asserted that the 'year of magical investing' is over.
Redditors Are Buying Eli Lilly And Co (LLY) Ahead of Potential End of AI Trade. Here's Why
Eli Lilly And Co (NYSE:LLY) recently posted strong quarterly results amid robust growth from its diabetes and weight-loss products.
15 Best Stocks to Buy for Medium Term
The market is attempting to recover from last week’s losses as investors regroup after a sharp sell-off that hit both tech and crypto.
Top 10 Non-AI Stocks Redditors are Buying Ahead of Potential Bubble Burst
Tim Seymour, Seymour Asset Management CIO, said in a recent program on CNBC that markets remain worried about AI valuations and “circular investments” despite the strong quarterly results from Nvidia...
Jim Cramer Comments On Eli Lilly (LLY)'s Shares After Pfizer CEO's Remarks
As he discussed Amgen, it was unsurprising that weight loss drug giant Eli Lilly and Company (NYSE:LLY) also caught Cramer’s attention.
8 Stocks Jim Cramer Discussed & Mentioned An Important Quantum Computing Development
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer continued his hard-hitting discussions of quantum computing.
15 Best Aggressive Growth Stocks to Buy Right Now
On November 14, Reuters reported that big hedge funds on Wall Street reduced their investments in the “Magnificent Seven” stocks in the third quarter.
Eli Lilly's (LLY) "a Great Company," Says Jim Cramer
Cramer has again started to frequently discuss Eli Lilly and Company (NYSE:LLY) on his morning show.